\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\:\\ blood\\ pressure\\ 122\\/64\\,\\ pulse\\ 84\\,\\ respiratory\\ rate\\ 12\\,\\ temperature\\ 36\\.8\\,\\ oxygen\\ saturation\\ 92\\%\\ on\\ room\\ air\\.\\ \\ patient\\ is\\ an\\ obese\\ female\\ in\\ no\\ acute\\ distress\\.\\ \\ alert\\ and\\ oriented\\ to\\ person\\,\\ time\\,\\ and\\ place\\.\\ \\ extraoccular\\ movements\\ intact\\.\\ \\ pupils\\ equal\\ and\\ reactive\\ to\\ light\\.\\ moist\\ mucous\\ membranes\\ with\\ clear\\ oropharynx\\.\\ \\ neck\\ supple\\ without\\ thyromegaly\\.\\ \\ regular\\ heart\\ rate\\ and\\ rhythm\\.\\ normal\\ s1\\ and\\ s2\\ without\\ appreciable\\ murmur\\,\\ rub\\ or\\ gallop\\.\\ no\\ jvd\\.\\ \\ diminished\\ breath\\ sounds\\ bilaterally\\.\\ no\\ wheezes\\,\\ rales\\,\\ or\\ rhonchi\\.\\ normal\\ bowel\\ sounds\\.\\ \\ soft\\ nontender\\,\\ nondistended\\.\\ \\ 1\\+\\ pitting\\ edema\\ in\\ bilateral\\ lower\\ extremities\\.\\ no\\ clubbing\\ or\\ cyanosis\\.\\ \\ neuro\\ exam\\ grossly\\ normal\\.\ \(0\)\
\-\ labs\\:\\ sodium\\ 139\\,\\ potassium\\ 4\\.8\\,\\ chloride\\ 101\\,\\ bicarbonate\\ 29\\,\\ bun\\ 6\\,\\ creatinine\\ 0\\.7\\,\\ glucose\\ 92\\,\\ calcium\\ 9\\.5\\.\\ hemoglobin\\ 14\\.4\\,\\ hematocrit\\ 41\\.2\\,\\ wbc\\ 7\\.8\\,\\ platelets\\ 241\\,000\\.\\ \\ ekg\\:\\ nsr\\.\ \(0\)\
\-\ treatment\\:\\ most\\ patients\\ are\\ treated\\ symptomatically\\.\\ \\ recurrent\\ pneumothoraces\\ are\\ treated\\ with\\ pleural\\ abrasion\\,\\ pleurodesis\\,\\ or\\ pleurectomy\\.\\ \\ chylous\\ effusion\\ can\\ be\\ managed\\ with\\ thoracentesis\\,\\ chemical\\ pleurodesis\\,\\ or\\ partial\\ pleurectomy\\.\\ antiestrogen\\ measures\\ have\\ also\\ been\\ employed\\:\\ surgical\\ oophorectomy\\,\\ ovarian\\ irradiation\\,\\ hormonal\\ therapy\\ \\(tamoxifen\\,\\ gonadotrophin\\ releasing\\ hormone\\ agonist\\,\\ luteinizing\\ hormone\\ releasing\\ hormone\\,\\ and\\ progesterone\\ administration\\)\\.\\ \\ lung\\ transplantation\\ may\\ be\\ performed\\ in\\ end\\-stage\\ disease\\.\ \(0\)\
\-\ follow\\-up\\:\\ lung\\ function\\ decline\\ in\\ lam\\ patients\\ is\\ measured\\ with\\ fev\\-1\\.\\ \\ cardiopulmonary\\ exercise\\ testing\\ is\\ using\\ to\\ determine\\ supplemental\\ oxygen\\ requirements\\ and\\ may\\ provide\\ helpful\\ referral\\ parameters\\ for\\ lung\\ transplantation\\.\ \(0\)\
\-\ \\â\\€\\¢\\ cxr\\:\\ lungs\\ clear\\.\\ \\ cardiomegaly\\.\ \(0\)\
\-\ \\â\\€\\¢\\ ct\\ chest\\:\\ multiple\\ bilateral\\ and\\ diffuse\\ thin\\-walled\\ cysts\\ relatively\\ homogeneous\\ in\\ size\\.\ \(0\)\
\-\ lymphangioleiomyomatosis\ \(13\)\
\-\ \\â\\€\\¢\\ langerhans\\ cell\\ histiocytosis\\ \\(eosinophilic\\ granuloma\\)\ \(0\)\
\-\ \\â\\€\\¢\\ centrilobular\\ emphysema\ \(0\)\
\-\ \\â\\€\\¢\\ lymphocytic\\ interstitial\\ pneumonia\ \(0\)\
\-\ \\â\\€\\¢\\ cystic\\ bronchiectasis\ \(0\)\
\-\ \\â\\€\\¢\\ idiopathic\\ pulmonary\\ fibrosis\ \(0\)\
\-\ 40\\ year\\ old\\ woman\\ with\\ history\\ of\\ hypertension\\,\\ obstructive\\ sleep\\ apnea\\ on\\ cpap\\,\\ and\\ morbid\\ obesity\\.\\ \\ multiple\\ hospitalizations\\ for\\ shortness\\ of\\ breath\\.\ \(0\)\
\-\ lymphangioleiomyomatosis\\ \\(lam\\)\\ is\\ a\\ rare\\ interstitial\\ lung\\ disease\\ that\\ affects\\ only\\ women\\,\\ typically\\ during\\ their\\ reproductive\\ years\\.\\ a\\ small\\ percentage\\ of\\ patients\\,\\ also\\ usually\\ women\\,\\ have\\ lam\\ in\\ association\\ with\\ tuberous\\ sclerosis\\.\\ lam\\ is\\ characterized\\ by\\ the\\ abnormal\\ proliferation\\ of\\ smooth\\ muscle\\ cells\\ in\\ the\\ lungs\\ and\\ in\\ the\\ thoracic\\ and\\ retroperitoneal\\ lymphatics\\.\\ affected\\ patients\\ are\\ also\\ at\\ risk\\ of\\ developing\\ renal\\ hamartomas\\ and\\ angiomyolipomas\\.\\ patients\\ with\\ lam\\ characteristically\\ present\\ with\\ chronic\\ cough\\ and\\ dyspnea\\ and\\ less\\ commonly\\ with\\ spontaneous\\ pneumothorax\\.\\ at\\ radiography\\,\\ lam\\ manifests\\ with\\ normal\\ to\\ increased\\ lung\\ volumes\\ and\\ interstitial\\ reticular\\ opacities\\ that\\ are\\ often\\ subtle\\.\\ unilateral\\ pneumothorax\\ and\\ unilateral\\ or\\ bilateral\\ chylous\\ pleural\\ effusions\\ are\\ frequent\\ radiographic\\ findings\\.\\ computed\\ tomography\\ \\(ct\\)\\ demonstrates\\ bilateral\\ diffuse\\ thin\\-walled\\ cysts\\ surrounded\\ by\\ normal\\ lung\\ parenchyma\\.\\ ct\\ may\\ also\\ demonstrate\\ associated\\ chylous\\ pleural\\ effusions\\ or\\ pneumothorax\\ and\\ thoracic\\ or\\ abdominal\\ lymphadenopathy\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ lam\\:\\ 0\\.07447778557857056\ \(0\)\
\-\ chylous\\:\\ 0\\.04777865437297972\ \(0\)\
\-\ pleurodesis\\:\\ 0\\.029134212011163167\ \(0\)\
\-\ pleurectomy\\:\\ 0\\.029134212011163167\ \(0\)\
\-\ releasing\\:\\ 0\\.029134212011163167\ \(0\)\
\-\ lung\\:\\ 0\\.029119519061632307\ \(0\)\
\-\ hormone\\:\\ 0\\.028501332414202215\ \(0\)\
\-\ interstitial\\:\\ 0\\.02459287903374625\ \(0\)\
\-\ thin\\-walled\\:\\ 0\\.024512035554921416\ \(0\)\
\-\ lymphangioleiomyomatosis\\:\\ 0\\.02422141605627937\ \(0\)\
\-\ pneumothorax\\:\\ 0\\.02359704340725436\ \(0\)\
\-\ 92\\:\\ 0\\.023460019921216792\ \(0\)\
\-\ transplantation\\:\\ 0\\.022274604737401366\ \(0\)\
\-\ patients\\:\\ 0\\.021682103915353194\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.021508040119943558\ \(0\)\
\-\ pleural\\:\\ 0\\.019519707051019387\ \(0\)\
\-\ oxygen\\:\\ 0\\.019229393798189616\ \(0\)\
\-\ \\,\\:\\ 0\\.01857814175118639\ \(0\)\
\-\ \\:\\:\\ 0\\.017729801035147687\ \(0\)\
\-\ 122\\/64\\:\\ 0\\.017285330243071564\ \(0\)\
\-\ 36\\.8\\:\\ 0\\.017285330243071564\ \(0\)\
\-\ 9\\.5\\.\\:\\ 0\\.017285330243071564\ \(0\)\
\-\ 41\\.2\\:\\ 0\\.017285330243071564\ \(0\)\
\-\ 241\\,000\\.\\:\\ 0\\.017285330243071564\ \(0\)\
\-\ antiestrogen\\:\\ 0\\.017285330243071564\ \(0\)\
\-\ gonadotrophin\\:\\ 0\\.017285330243071564\ \(0\)\
\-\ agonist\\:\\ 0\\.017285330243071564\ \(0\)\
\-\ fev\\-1\\:\\ 0\\.017285330243071564\ \(0\)\
\-\ effusions\\:\\ 0\\.017102631873384275\ \(0\)\
\-\ unilateral\\:\\ 0\\.016630617433188687\ \(0\)\
\-\ women\\:\\ 0\\.01628266403864483\ \(0\)\
\-\ bilateral\\:\\ 0\\.016265237092662307\ \(0\)\
\-\ extraoccular\\:\\ 0\\.015926218124326576\ \(0\)\
\-\ luteinizing\\:\\ 0\\.015926218124326576\ \(0\)\
\-\ or\\:\\ 0\\.015710160768058156\ \(0\)\
\-\ 14\\.4\\:\\ 0\\.015131188500585075\ \(0\)\
\-\ nsr\\:\\ 0\\.014567106005581584\ \(0\)\
\-\ requirements\\:\\ 0\\.014567106005581584\ \(0\)\
\-\ morbid\\:\\ 0\\.014567106005581584\ \(0\)\
\-\ bicarbonate\\:\\ 0\\.014129569630455682\ \(0\)\
\-\ symptomatically\\:\\ 0\\.014129569630455682\ \(0\)\
\-\ pitting\\:\\ 0\\.013469820146884677\ \(0\)\
\-\ abrasion\\:\\ 0\\.013469820146884677\ \(0\)\
\-\ oophorectomy\\:\\ 0\\.013469820146884677\ \(0\)\
\-\ lymphatics\\:\\ 0\\.013469820146884677\ \(0\)\
\-\ sounds\\:\\ 0\\.013366065303946587\ \(0\)\
\-\ also\\:\\ 0\\.013212702695452168\ \(0\)\
\-\ rub\\:\\ 0\\.013207993886836591\ \(0\)\
\-\ gallop\\:\\ 0\\.013207993886836591\ \(0\)\
\-\ 139\\:\\ 0\\.013207993886836591\ \(0\)\
\-\ progesterone\\:\\ 0\\.013207993886836591\ \(0\)\
\-\ hospitalizations\\:\\ 0\\.013207993886836591\ \(0\)\
\-\ reproductive\\:\\ 0\\.013207993886836591\ \(0\)\
\-\ normal\\:\\ 0\\.013133455437246089\ \(0\)\
\-\ cysts\\:\\ 0\\.013127287383652418\ \(0\)\
\-\ rate\\:\\ 0\\.013061652903826836\ \(0\)\
\-\ 7\\.8\\:\\ 0\\.012977046758098585\ \(0\)\
\-\ pneumothoraces\\:\\ 0\\.012977046758098585\ \(0\)\
\-\ thoracentesis\\:\\ 0\\.012977046758098585\ \(0\)\
\-\ tamoxifen\\:\\ 0\\.012977046758098585\ \(0\)\
\-\ thoracic\\:\\ 0\\.01291787257295785\ \(0\)\
\-\ cpap\\:\\ 0\\.01277045751171069\ \(0\)\
\-\ lungs\\:\\ 0\\.012689367050903042\ \(0\)\
\-\ thyromegaly\\:\\ 0\\.012583574806212014\ \(0\)\
\-\ supplemental\\:\\ 0\\.012583574806212014\ \(0\)\
\-\ centrilobular\\:\\ 0\\.012583574806212014\ \(0\)\
\-\ breath\\:\\ 0\\.012529872777448424\ \(0\)\
\-\ 101\\:\\ 0\\.012412964263095093\ \(0\)\
\-\ parameters\\:\\ 0\\.012412964263095093\ \(0\)\
\-\ clear\\:\\ 0\\.012390300443712336\ \(0\)\
\-\ 4\\.8\\:\\ 0\\.012256017777460708\ \(0\)\
\-\ chloride\\:\\ 0\\.012256017777460708\ \(0\)\
\-\ irradiation\\:\\ 0\\.012256017777460708\ \(0\)\
\-\ manifests\\:\\ 0\\.012110708028139685\ \(0\)\
\-\ hormonal\\:\\ 0\\.011975427887969192\ \(0\)\
\-\ end\\-stage\\:\\ 0\\.011975427887969192\ \(0\)\
\-\ hamartomas\\:\\ 0\\.011975427887969192\ \(0\)\
\-\ angiomyolipomas\\:\\ 0\\.011975427887969192\ \(0\)\
\-\ potassium\\:\\ 0\\.011730009960608396\ \(0\)\
\-\ apnea\\:\\ 0\\.011617934639353596\ \(0\)\
\-\ percentage\\:\\ 0\\.011617934639353596\ \(0\)\
\-\ jvd\\:\\ 0\\.011511920480000114\ \(0\)\
\-\ employed\\:\\ 0\\.011511920480000114\ \(0\)\
\-\ characteristically\\:\\ 0\\.011511920480000114\ \(0\)\
\-\ are\\:\\ 0\\.011420332083623546\ \(0\)\
\-\ 1\\+\\:\\ 0\\.011315678404398186\ \(0\)\
\-\ 0\\.7\\:\\ 0\\.011315678404398186\ \(0\)\
\-\ appreciable\\:\\ 0\\.011224462687467024\ \(0\)\
\-\ decline\\:\\ 0\\.011224462687467024\ \(0\)\
\-\ cardiopulmonary\\:\\ 0\\.011224462687467024\ \(0\)\
\-\ volumes\\:\\ 0\\.011224462687467024\ \(0\)\
\-\ sodium\\:\\ 0\\.011137302368700683\ \(0\)\
\-\ may\\:\\ 0\\.011025460993518376\ \(0\)\
\-\ nondistended\\:\\ 0\\.010896905658715718\ \(0\)\
\-\ platelets\\:\\ 0\\.010896905658715718\ \(0\)\
\-\ reticular\\:\\ 0\\.010896905658715718\ \(0\)\
\-\ person\\:\\ 0\\.010822905015612096\ \(0\)\
\-\ lymphocytic\\:\\ 0\\.01068278939996083\ \(0\)\
\-\ moist\\:\\ 0\\.010616315769224201\ \(0\)\
\-\ 84\\:\\ 0\\.010552021998983044\ \(0\)\
\-\ oropharynx\\:\\ 0\\.01048976964934661\ \(0\)\
\-\ obesity\\:\\ 0\\.01048976964934661\ \(0\)\
\-\ supple\\:\\ 0\\.010370897841863406\ \(0\)\
\-\ clubbing\\:\\ 0\\.010370897841863406\ \(0\)\
\-\ chemical\\:\\ 0\\.010314059534268793\ \(0\)\
\-\ hemoglobin\\:\\ 0\\.01020509904180838\ \(0\)\
\-\ diffuse\\:\\ 0\\.010145127138726725\ \(0\)\
\-\ wheezes\\:\\ 0\\.010101876034974219\ \(0\)\
\-\ rhonchi\\:\\ 0\\.010101876034974219\ \(0\)\
\-\ ekg\\:\\ 0\\.010101876034974219\ \(0\)\
\-\ proliferation\\:\\ 0\\.010101876034974219\ \(0\)\
\-\ treated\\:\\ 0\\.010030787592485723\ \(0\)\
\-\ langerhans\\:\\ 0\\.009910428055437128\ \(0\)\
\-\ saturation\\:\\ 0\\.009865350568722033\ \(0\)\
\-\ hematocrit\\:\\ 0\\.009865350568722033\ \(0\)\
\-\ membranes\\:\\ 0\\.009821286145482703\ \(0\)\
\-\ cyanosis\\:\\ 0\\.009821286145482703\ \(0\)\
\-\ cardiomegaly\\:\\ 0\\.009778190249955692\ \(0\)\
\-\ bronchiectasis\\:\\ 0\\.009778190249955692\ \(0\)\
\-\ obese\\:\\ 0\\.009694740025605112\ \(0\)\
\-\ mucous\\:\\ 0\\.009654310050697787\ \(0\)\
\-\ surrounded\\:\\ 0\\.009575868218121905\ \(0\)\
\-\ creatinine\\:\\ 0\\.009537793539970725\ \(0\)\
\-\ affects\\:\\ 0\\.009537793539970725\ \(0\)\
\-\ radiography\\:\\ 0\\.009537793539970725\ \(0\)\
\-\ referral\\:\\ 0\\.009500444138067405\ \(0\)\
\-\ sleep\\:\\ 0\\.009500444138067405\ \(0\)\
\-\ temperature\\:\\ 0\\.009463792896867105\ \(0\)\
\-\ provide\\:\\ 0\\.009392483790649704\ \(0\)\
\-\ histiocytosis\\:\\ 0\\.009323677281215841\ \(0\)\
\-\ bun\\:\\ 0\\.00925720365047921\ \(0\)\
\-\ s2\\:\\ 0\\.009224793254496445\ \(0\)\
\-\ rales\\:\\ 0\\.009224793254496445\ \(0\)\
\-\ tuberous\\:\\ 0\\.009224793254496445\ \(0\)\
\-\ pupils\\:\\ 0\\.009161536661911697\ \(0\)\
\-\ diminished\\:\\ 0\\.009161536661911697\ \(0\)\
\-\ emphysema\\:\\ 0\\.009161536661911697\ \(0\)\
\-\ movements\\:\\ 0\\.009100257164844824\ \(0\)\
\-\ measured\\:\\ 0\\.009100257164844824\ \(0\)\
\-\ managed\\:\\ 0\\.009011785723118414\ \(0\)\
\-\ eosinophilic\\:\\ 0\\.008983160626214194\ \(0\)\
\-\ glucose\\:\\ 0\\.008954947415523802\ \(0\)\
\-\ tomography\\:\\ 0\\.008954947415523802\ \(0\)\
\-\ retroperitoneal\\:\\ 0\\.008927134405735653\ \(0\)\
\-\ computed\\:\\ 0\\.008845986923063388\ \(0\)\
\-\ grossly\\:\\ 0\\.008793696242510132\ \(0\)\
\-\ equal\\:\\ 0\\.008768064710025126\ \(0\)\
\-\ developing\\:\\ 0\\.008768064710025126\ \(0\)\
\-\ 29\\:\\ 0\\.008742763916229229\ \(0\)\
\-\ opacities\\:\\ 0\\.008742763916229229\ \(0\)\
\-\ rhythm\\:\\ 0\\.008693121155475717\ \(0\)\
\-\ murmur\\:\\ 0\\.008668763273125607\ \(0\)\
\-\ helpful\\:\\ 0\\.008668763273125607\ \(0\)\
\-\ pulse\\:\\ 0\\.008644704268043618\ \(0\)\
\-\ s1\\:\\ 0\\.008644704268043618\ \(0\)\
\-\ neuro\\:\\ 0\\.008644704268043618\ \(0\)\
\-\ obstructive\\:\\ 0\\.008620936894450783\ \(0\)\
\-\ nontender\\:\\ 0\\.008597454166908203\ \(0\)\
\-\ exercise\\:\\ 0\\.008597454166908203\ \(0\)\
\-\ determine\\:\\ 0\\.008484082459283056\ \(0\)\
\-\ frequent\\:\\ 0\\.008376909101365675\ \(0\)\
\-\ alert\\:\\ 0\\.00835615986738423\ \(0\)\
\-\ characterized\\:\\ 0\\.008335627906860122\ \(0\)\
\-\ granuloma\\:\\ 0\\.008236074327696546\ \(0\)\
\-\ oriented\\:\\ 0\\.008216756099376915\ \(0\)\
\-\ calcium\\:\\ 0\\.008197626344582083\ \(0\)\
\-\ place\\:\\ 0\\.008141332019322415\ \(0\)\
\-\ association\\:\\ 0\\.008141332019322415\ \(0\)\
\-\ testing\\:\\ 0\\.008104680778122115\ \(0\)\
\-\ reactive\\:\\ 0\\.007931046665687908\ \(0\)\
\-\ homogeneous\\:\\ 0\\.007931046665687908\ \(0\)\
\-\ dyspnea\\:\\ 0\\.007931046665687908\ \(0\)\
\-\ without\\:\\ 0\\.007890247711208472\ \(0\)\
\-\ light\\:\\ 0\\.007818048405223916\ \(0\)\
\-\ spontaneous\\:\\ 0\\.007818048405223916\ \(0\)\
\-\ regular\\:\\ 0\\.007726119805422248\ \(0\)\
\-\ subtle\\:\\ 0\\.007696410383813225\ \(0\)\
\-\ ovarian\\:\\ 0\\.007667144402996213\ \(0\)\
\-\ idiopathic\\:\\ 0\\.007638308819879163\ \(0\)\
\-\ fibrosis\\:\\ 0\\.007460555156608318\ \(0\)\
\-\ exam\\:\\ 0\\.007361701725292306\ \(0\)\
\-\ their\\:\\ 0\\.007334009036730728\ \(0\)\
\-\ smooth\\:\\ 0\\.007334009036730728\ \(0\)\
\-\ using\\:\\ 0\\.007273672451109642\ \(0\)\
\-\ have\\:\\ 0\\.007256619915157222\ \(0\)\
\-\ affected\\:\\ 0\\.007250048257940673\ \(0\)\
\-\ room\\:\\ 0\\.007203636995027133\ \(0\)\
\-\ measures\\:\\ 0\\.007169535538729351\ \(0\)\
\-\ relatively\\:\\ 0\\.007169535538729351\ \(0\)\
\-\ parenchyma\\:\\ 0\\.00713601704194641\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.007124970340538065\ \(0\)\
\-\ function\\:\\ 0\\.007103061907992721\ \(0\)\
\-\ recurrent\\:\\ 0\\.007070651512009956\ \(0\)\
\-\ cxr\\:\\ 0\\.007070651512009956\ \(0\)\
\-\ distress\\:\\ 0\\.007059966012465711\ \(0\)\
\-\ multiple\\:\\ 0\\.007058062758742231\ \(0\)\
\-\ 40\\:\\ 0\\.007049338429192497\ \(0\)\
\-\ shortness\\:\\ 0\\.007049338429192497\ \(0\)\
\-\ ct\\:\\ 0\\.007031197961129664\ \(0\)\
\-\ respiratory\\:\\ 0\\.006956196597849353\ \(0\)\
\-\ administration\\:\\ 0\\.006956196597849353\ \(0\)\
\-\ pneumonia\\:\\ 0\\.006926107245546097\ \(0\)\
\-\ 12\\:\\ 0\\.006857643980631925\ \(0\)\
\-\ no\\:\\ 0\\.006748581574147467\ \(0\)\
\-\ cells\\:\\ 0\\.006718522929705877\ \(0\)\
\-\ partial\\:\\ 0\\.00670069749499754\ \(0\)\
\-\ in\\:\\ 0\\.006610152629651058\ \(0\)\
\-\ hypertension\\:\\ 0\\.006605453043725859\ \(0\)\
\-\ pressure\\:\\ 0\\.006580260607494783\ \(0\)\
\-\ extremities\\:\\ 0\\.006571934546942918\ \(0\)\
\-\ rare\\:\\ 0\\.006506569017006463\ \(0\)\
\-\ cough\\:\\ 0\\.006420107605506023\ \(0\)\
\-\ effusion\\:\\ 0\\.006367007686677258\ \(0\)\
\-\ radiographic\\:\\ 0\\.006359538023115164\ \(0\)\
\-\ commonly\\:\\ 0\\.006322610673442434\ \(0\)\
\-\ intact\\:\\ 0\\.006154440434702385\ \(0\)\
\-\ wbc\\:\\ 0\\.006107989903089827\ \(0\)\
\-\ risk\\:\\ 0\\.006069032641880562\ \(0\)\
\-\ sclerosis\\:\\ 0\\.006018265163581068\ \(0\)\
\-\ muscle\\:\\ 0\\.006018265163581068\ \(0\)\
\-\ and\\:\\ 0\\.006000300191073948\ \(0\)\
\-\ typically\\:\\ 0\\.0059145603323646516\ \(0\)\
\-\ labs\\:\\ 0\\.00582740001359831\ \(0\)\
\-\ heart\\:\\ 0\\.0058217248017819094\ \(0\)\
\-\ that\\:\\ 0\\.005788159719838523\ \(0\)\
\-\ less\\:\\ 0\\.005674392165338593\ \(0\)\
\-\ air\\:\\ 0\\.005669142405003855\ \(0\)\
\-\ \\(\\:\\ 0\\.005665582166618514\ \(0\)\
\-\ size\\:\\ 0\\.00561740366937014\ \(0\)\
\-\ \\)\\:\\ 0\\.005596374055790628\ \(0\)\
\-\ by\\:\\ 0\\.00557988589507794\ \(0\)\
\-\ is\\:\\ 0\\.00551265469004633\ \(0\)\
\-\ bilaterally\\:\\ 0\\.00550334360494883\ \(0\)\
\-\ disease\\:\\ 0\\.005477402122414526\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.005451052924395573\ \(0\)\
\-\ often\\:\\ 0\\.005346026565724808\ \(0\)\
\-\ bowel\\:\\ 0\\.005254810848793645\ \(0\)\
\-\ be\\:\\ 0\\.005167673424878154\ \(0\)\
\-\ during\\:\\ 0\\.005127469117497663\ \(0\)\
\-\ usually\\:\\ 0\\.005088094615425018\ \(0\)\
\-\ only\\:\\ 0\\.005038062075460658\ \(0\)\
\-\ renal\\:\\ 0\\.005034265783251116\ \(0\)\
\-\ 6\\:\\ 0\\.00500415717916642\ \(0\)\
\-\ neck\\:\\ 0\\.004920084582389181\ \(0\)\
\-\ years\\:\\ 0\\.004920084582389181\ \(0\)\
\-\ pulmonary\\:\\ 0\\.004895196686706006\ \(0\)\
\-\ cystic\\:\\ 0\\.004832613151474036\ \(0\)\
\-\ abnormal\\:\\ 0\\.00477861223591159\ \(0\)\
\-\ edema\\:\\ 0\\.00473906566555155\ \(0\)\
\-\ time\\:\\ 0\\.004732551425959437\ \(0\)\
\-\ chronic\\:\\ 0\\.004719587515503922\ \(0\)\
\-\ performed\\:\\ 0\\.004671722218092782\ \(0\)\
\-\ blood\\:\\ 0\\.004573355044135881\ \(0\)\
\-\ been\\:\\ 0\\.0045584213518901785\ \(0\)\
\-\ at\\:\\ 0\\.004540247658163267\ \(0\)\
\-\ cell\\:\\ 0\\.004525962179571541\ \(0\)\
\-\ therapy\\:\\ 0\\.004479687835765907\ \(0\)\
\-\ abdominal\\:\\ 0\\.004188076937494343\ \(0\)\
\-\ acute\\:\\ 0\\.004137018292365677\ \(0\)\
\-\ physical\\:\\ 0\\.004110794646237722\ \(0\)\
\-\ increased\\:\\ 0\\.004098989768234619\ \(0\)\
\-\ soft\\:\\ 0\\.004080248556850098\ \(0\)\
\-\ chest\\:\\ 0\\.004009272549132389\ \(0\)\
\-\ associated\\:\\ 0\\.003953848160603337\ \(0\)\
\-\ \\%\\:\\ 0\\.003908472614403936\ \(0\)\
\-\ woman\\:\\ 0\\.0038703979362527574\ \(0\)\
\-\ most\\:\\ 0\\.003868304199466816\ \(0\)\
\-\ small\\:\\ 0\\.0038599515380021935\ \(0\)\
\-\ demonstrate\\:\\ 0\\.003855788512417727\ \(0\)\
\-\ can\\:\\ 0\\.00380043598523347\ \(0\)\
\-\ present\\:\\ 0\\.0037843308900621193\ \(0\)\
\-\ lower\\:\\ 0\\.0037683569987526718\ \(0\)\
\-\ demonstrates\\:\\ 0\\.003660041571868992\ \(0\)\
\-\ findings\\:\\ 0\\.0035663469329214894\ \(0\)\
\-\ surgical\\:\\ 0\\.0035220034710812813\ \(0\)\
\-\ female\\:\\ 0\\.0034446279832310465\ \(0\)\
\-\ treatment\\:\\ 0\\.0033914058031389942\ \(0\)\
\-\ to\\:\\ 0\\.003349553791709696\ \(0\)\
\-\ for\\:\\ 0\\.002859247641736138\ \(0\)\
\-\ on\\:\\ 0\\.0028387882837859926\ \(0\)\
\-\ \\.\\:\\ 0\\.0027146704074441272\ \(0\)\
\-\ an\\:\\ 0\\.0023169899299700586\ \(0\)\
\-\ history\\:\\ 0\\.00231414615236683\ \(0\)\
\-\ with\\:\\ 0\\.0022941995311743083\ \(0\)\
\-\ year\\:\\ 0\\.001874716214260617\ \(0\)\
\-\ old\\:\\ 0\\.0017155580330632443\ \(0\)\
\-\ patient\\:\\ 0\\.0016795920214046822\ \(0\)\
\-\ a\\:\\ 0\\.001555293340465103\ \(0\)\
\-\ of\\:\\ 0\\.0011421941254704747\ \(0\)\
\-\ the\\:\\ 0\\.0008132310864919165\ \(0\)\
